Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. UG
UG logo

UG Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
6.660
Open
6.660
VWAP
6.66
Vol
999.00
Mkt Cap
30.60M
Low
6.660
Amount
6.65K
EV/EBITDA(TTM)
9.35
Total Shares
4.59M
EV
21.98M
EV/OCF(TTM)
11.17
P/S(TTM)
2.90
United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
Show More

Events Timeline

(ET)
2025-11-06
09:04:50
United-Guardian Announces Q3 Earnings Per Share of 6 Cents Compared to 19 Cents Last Year
select
2025-08-08 (ET)
2025-08-08
09:05:14
United-Guardian reports Q2 EPS 14c vs 21c
select
2025-05-21 (ET)
2025-05-21
09:05:44
United-Guardian appoints Donna Vigilante to board of directors
select
2025-05-08 (ET)
2025-05-08
09:03:12
United-Guardian reports Q1 EPS 12c vs 20c last year
select
2025-03-21 (ET)
2025-03-21
09:04:32
United-Guardian reports FY24 EPS 71c vs 56c last year
select
2024-11-08 (ET)
2024-11-08
08:05:08
United-Guardian reports Q3 EPS 19c vs. 14c last year
select

News

Yahoo Finance
8.5
04-15Yahoo Finance
Debt-Free Canadian Gold Miners Attracting Investors Amid Market Uncertainty
  • Market Appeal: Amid patchy global growth signals, rising inflation, and energy costs, investors are increasingly gravitating towards debt-free Canadian junior gold miners, which not only offer potential exploration upside but also avoid interest costs, enhancing their investment appeal.
  • Upside Gold Overview: Upside Gold's Kena Gold-Copper Project spans over 10,000 hectares in British Columbia, hosting a historical gold resource of approximately 3.33 million ounces and a market cap of CA$59.8 million; future exploration activities, particularly the 2026 drilling campaign, could significantly influence investor perception.
  • Eskay Mining Potential: Eskay Mining focuses on the ESKAY Corey property in British Columbia, with a market cap of CA$80.2 million; despite facing high risks and ongoing losses, its AI-driven exploration plans and debt-free balance sheet may attract investors seeking high-potential opportunities.
  • Canterra Minerals Outlook: Canterra Minerals, with a market cap of CA$68.2 million, targets early-stage mineral projects across Newfoundland, Alberta, and Ontario; despite experiencing an average annual earnings decline of 9.6%, its fully funded 2026 drilling program and recent high-grade gold discoveries could signal a turning point, drawing investor interest.
Yahoo Finance
8.5
04-10Yahoo Finance
Upside Gold Updates Kena Project Data, Reveals Larger Mineralized System
  • Expanded Mineralization: Upside Gold's historic data compilation at the Kena Gold-Copper Project reveals a mineralized system extending 7 kilometers beyond previous resource definitions, indicating potential for a multi-million-ounce asset that could attract increased investor interest.
  • New Drill Targets Identified: The integration of decades of geological data into a modern 3D model has identified multiple high-priority drill targets, laying the groundwork for the 2026 exploration program and enhancing confidence in the project's long-term potential.
  • Multi-Metal Potential: The updated findings uncover significant copper and silver values that were previously overlooked, suggesting that Kena is not just a gold project but a multi-metal deposit, thereby enhancing its overall economic potential.
  • Valuation Upside Expected: Analysts estimate that Upside Gold is currently 76% undervalued, and with resource expansion and exploration progress, a resource upgrade is anticipated by 2027, further boosting the company's valuation.
seekingalpha
9.5
03-27seekingalpha
United-Guardian Reports Decline in Revenue Amid Market Challenges
  • Earnings Highlights: United-Guardian's FY report reveals a GAAP EPS of $0.46, indicating stable profitability; however, revenue fell to $10.54 million, down 13.5% year-over-year, reflecting challenges in the market environment.
  • Revenue Decline Reasons: The significant revenue drop is primarily attributed to the crisis in the Middle East, which has led to reduced consumer spending, thereby impacting the company's sales performance and highlighting the risks of operating in unstable markets.
  • Dividend Yield Analysis: Amid the current market conditions, United-Guardian's dividend yield has become a key metric for consumers, particularly as economic uncertainty rises, attracting investors seeking stable returns.
  • Future Outlook: Despite the pressure from declining revenues, United-Guardian must formulate effective strategies to navigate market fluctuations, maintain profitability, and bolster investor confidence.
NASDAQ.COM
9.5
03-27NASDAQ.COM
United-Guardian Reports Yearly Profit Decline
  • Annual Profit Decline: United-Guardian Inc reported a full-year profit of $2.11 million, or $0.46 per share, which represents a significant drop from last year's $3.25 million and $0.71 per share, indicating mounting pressure on the company's profitability.
  • Revenue Decrease: The company's revenue fell by 13.4%, from $12.18 million last year to $10.55 million this year, a trend that could negatively impact future investor confidence and market performance.
  • Profitability Challenges: With both revenue and profit declining, United-Guardian faces challenges to its profitability, necessitating strategic measures to restore growth and improve financial health.
  • Market Reaction Expectations: Investors may adopt a cautious outlook on the company's future performance, particularly in the current economic climate, as the decline in profitability could lead to stock price volatility.
NASDAQ.COM
6.5
2025-12-12NASDAQ.COM
Key Analyst Insights on Visa, Charles Schwab, and Amphenol
  • Zacks Research Daily Highlights: The report features research on 16 major stocks, including Visa, Charles Schwab, and Amphenol, along with two micro-cap stocks, Autoscope Technologies and United-Guardian, emphasizing unique insights into smaller companies.

  • Visa's Performance and Challenges: Visa has shown strong growth with an 11% revenue increase year-over-year, driven by digital payments and cross-border transactions, but faces rising costs and regulatory pressures that could impact margins.

  • Charles Schwab's Strategic Moves: Despite a 21.8% stock gain over the past year, Schwab is dealing with elevated expenses and market uncertainty, though strategic acquisitions and branch expansions are expected to drive client asset growth.

  • Amphenol's Growth Prospects: Amphenol has seen an 88.5% stock increase, benefiting from a diversified business model and strong demand in defense and IT sectors, although macroeconomic uncertainties and competition pose risks.

Benzinga
3.0
2025-11-28Benzinga
Three Risk-Averse Stocks Poised for Growth in Q4
  • Oversold Stocks Opportunity: The consumer staples sector has several oversold stocks, presenting potential buying opportunities for undervalued companies, particularly those with an RSI below 30.

  • SunOpta Inc Performance: SunOpta reported better-than-expected quarterly earnings but saw its stock drop 35% over the past month, with an RSI of 29.9 and a recent price increase of 6.2% to $3.58.

  • Energizer Holdings Inc Update: Energizer Holdings experienced mixed financial results and a 25% stock decline in the past month, with an RSI of 26 and shares closing at $18.10 after a 3.4% rise.

  • United-Guardian Inc Earnings Decline: United-Guardian's third-quarter earnings fell, leading to a 22% stock drop and an RSI of 21.4, with shares closing at $5.68 after a slight decrease.

Valuation Metrics

The current forward P/E ratio for United-Guardian Inc (UG.O) is 26.53, compared to its 5-year average forward P/E of 1.67. For a more detailed relative valuation and DCF analysis to assess United-Guardian Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
1.67
Current PE
26.53
Overvalued PE
8.30
Undervalued PE
-4.96

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding UG

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is United-Guardian Inc (UG) stock price today?

The current price of UG is 6.66 USD — it has increased 0.15

What is United-Guardian Inc (UG)'s business?

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.

What is the price predicton of UG Stock?

Wall Street analysts forecast UG stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for UG is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is United-Guardian Inc (UG)'s revenue for the last quarter?

United-Guardian Inc revenue for the last quarter amounts to 2.96M USD, increased 19.59

What is United-Guardian Inc (UG)'s earnings per share (EPS) for the last quarter?

United-Guardian Inc. EPS for the last quarter amounts to 0.14 USD, increased 27.27

How many employees does United-Guardian Inc (UG). have?

United-Guardian Inc (UG) has 23 emplpoyees as of April 22 2026.

What is United-Guardian Inc (UG) market cap?

Today UG has the market capitalization of 30.60M USD.